Pharma industry event in Mumbai will host 40,000 visitors on Nov. 17-23.
More than 40,000 pharma industry representatives are expected to attend CPhI India, scheduled for Nov. 17-23, 2016 in Mumbai. The event, now in its 10th year, includes P-MEC India and the first CPhI India Pharma Week. The exhibits, hosted at two venues simultaneously-the Bombay Exhibition Centre and at the MMRDA Grounds-will feature more than 1,200 exhibitors from more than 100 countries.
The first CPhI India Pharma Week will cover the themes of business, knowledge, leadership, innovation, recognition and networking, according to CPhI EMEA, the show organizers. The Pre-Connect Congress offers a knowledge-sharing platform featuring discussions, industry analysis, and interactive sessions. In addition, CPhI and P-MEC India will launch the CPhI Pharma Insights Report: India, covering the current market and future prospects for the pharma economy in the next 3–5 years. Other activities include the CPhI Women in Pharma Power Breakfast, a CEO roundtable, plant visits, and the UBM India Pharma Awards.
Additional features in 2016 include the CPhI Exhibitor Showcase, which allows exhibiting companies to present their products, services and new launches in 45-minute slots; the CPhI Innovation Gallery provides the opportunity for companies to showcase their innovations on an international platform in the Pharma Forum; a mobile app to help users access the exhibitor list, navigate floor plans, and connect with social media updates; and CPhI TV, which features interviews from the top companies on the show floor, broadcast during the event and online on the website
The Bombay Exhibition Centre will host exhibits for the following market segments:
The Bandra Kurla Complex will host exhibits for the following market segments:
For more information, visit www.cphi.com/india/
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.